Filter
143
Text search:
drug
import
Featured
Recommendations
10
New Publications
39
Language
Document type
No document type
64
Studies & Reports
31
Guidelines
28
Manuals
11
Strategic & Response Plan
5
Resource Platforms
2
Training Material
1
Fact sheets
1
Countries / Regions
Global
8
India
7
Kenya
6
Western and Central Europe
6
South Africa
5
South–East Asia Region
4
Sierra Leone
3
Senegal
3
Zimbabwe
3
Nepal
3
Bangladesh
3
Ukraine
3
Venezuela
3
Eastern Europe
3
Nigeria
2
Ethiopia
2
Ghana
2
Uganda
2
Lebanon
2
Zambia
2
Syria
2
Tanzania
2
Rwanda
2
Malawi
2
Liberia
1
Congo, Democratic Republic of
1
Philippines
1
South Sudan
1
Iraq
1
Afghanistan
1
Thailand
1
Mozambique
1
Namibia
1
North Macedonia
1
Botswana
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Asia
1
Africa
1
Tajikistan
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
9
Public Health
8
Pharmacy & Technologies
7
Key Resources
6
Women & Child Health
1
Toolboxes
AMR
20
COVID-19
12
HIV
10
Mental Health
10
Pharmacy
8
TB
7
Conflict
5
NCDs
3
Malaria
3
Rapid Response
2
Caregiver
2
Planetary Health
2
NTDs
2
Specific Hazards
1
Global Health Education
1
Social Ethics
1
Health Financing Toolbox
1
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
Policy Brief
Accessed: 20.11.2019
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
In 2005, the World Health Organization (WHO) Member States adopted the revised International
Health Regulations (IHR) (2005). The Regulations provide a unique public health framework in the
form of obligations and recommendations that enable countries to better p
...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p
...
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
Accessed November 2017
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP
...
